OCT 29, 2015 7:19 PM PDT

Poking Holes in Antibiotic Resistance

WRITTEN BY: Kerry Evans
The problem with antibiotics is that bacteria become resistant.  Researchers at the University of Illinois at Urbana-Champaign set out to tackle this issue by designing “resistance-proof” antibiotics.  Their first candidate, a helical antimicrobial polypeptide, just might fit the bill.  

Antimicrobial peptides (AMPs) are rather widespread in nature (they are found in honey, for example). AMPs typically consist of 12 to 50 positively charged and nonpolar amino acids, and take on numerous secondary structures including alpha helices and beta strands.  The majority of AMPs kill bacteria (as well as some viruses and fungi) by disrupting their cell membranes.  The positively charged amino acids are attracted to the negatively charged membrane, and the nonpolar amino acids allow the AMP to interact with the hydrophobic membrane lipids.  These interactions disrupt the membrane, killing the cells.  
 
Antimicrobial peptides come in a variety of structures.

The University of Illinois team, let by Jianjun Cheng, faced a number of challenges when designing an AMP for therapeutic use.  For example, human cells are not immune to AMP activity, and many AMPs are quickly degraded by proteases once they enter the body.  

To overcome these issues, the team designed an AMP with a “radially amphiphilic structure” - a so-called “RA polypeptide”.  What this means is that the positively charged amino acids lie on the outside of the polypeptide, and the hydrophobic amino acids lie on the inside.  The team reasoned that such a design would prevent the RA polypeptides from aggregating and interacting with other components in the blood. In addition, the positively charged amino acids on the surface of the polypeptide should attract it to the negatively charged bacterial membranes.

The researchers plan to use their RA polypeptides in conjunction with traditional antibiotics.  According to Cheng, “the polypeptides punch holes in the membrane, which make it very easy for other drugs to go through and bypass some of the drug-resistant mechanisms … together, they work even better than a single agent”.

Sources: PNAS, Phys.org, Wikipedia
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 25, 2019
Microbiology
NOV 25, 2019
Salmonella is Getting Meaner
Salmonella infections are growing increasingly resistant to antibiotics, and are beginning to affect more adults instead of just children and the elderly....
NOV 28, 2019
Microbiology
NOV 28, 2019
Measles Outbreaks Strike Samoa, DRC
The largest measles outbreak in the world is now occurring in the Democratic Republic of Congo. Over 5,000 people have died from the illness....
DEC 23, 2019
Microbiology
DEC 23, 2019
Snow-Loving Algae Thrive at the Heights of the Andes
The Andes Mountain range runs along the edge of western South America. Microbial life has found a home high in those mountains....
JAN 19, 2020
Genetics & Genomics
JAN 19, 2020
Engineering Mosquitoes to Stop Dengue Virus Transmission
The dengue virus is transmitted by mosquitoes. It is found in over one hundred countries and threatens three billion people with a serious illness....
FEB 11, 2020
Clinical & Molecular DX
FEB 11, 2020
Portable device turns smartphones into diagnostic labs
Your smartphone lets you connect with friends, stores your memories, sends work emails and pays for your groceries. Soon, it could even help diagnose if yo...
FEB 10, 2020
Microbiology
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries....
Loading Comments...